RHO and cancer: Research has shown that DLC1, as a gene from the same family as GMIP, acts as a tumour suppressor in hepatocellular carcinoma and provides evidence supporting the hypothesis that DLC1 inhibits cancer cell growth by negatively regulating Rho protein activity [12, 17].